Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome
Open Access
- 9 May 2022
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 79 (6) , 565-574
Abstract
Down syndrome (DS) is most often caused by trisomy 21, which results from an extra copy of chromosome 21 that encodes no fewer than 350 genes,1 including APP (OMIM 104760); this gene encodes the amyloid precursor protein, APP, whose cleavage products include the amyloid-β (Aβ) peptide. This process results in generation of excess full-length APP and Aβ. In individuals with DS, diffuse Aβ deposits are visible in the cerebral cortex as early as age 12 years.2 Fibrillar amyloid plaques are observed in almost all individuals with DS after age 40 years.3-5 The lifetime risk of AD among individuals with DS is approximately 90%6; as a result, AD is the leading cause of death among adults with DS older than 35 years.7Keywords
This publication has 27 references indexed in Scilit:
- TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell–independent isotype switch in miceBlood, 2013
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive declineNature, 2012
- Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding DiseasesJournal of Biological Chemistry, 2011
- Increased Soluble APPα, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome PatientsAlzheimer Disease & Associated Disorders, 2010
- Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic miceProceedings of the National Academy of Sciences, 2007
- Alzheimer disease and Down syndrome: factors in pathogenesisNeurobiology of Aging, 2005
- The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary Clinical ValidityJournal of Clinical and Experimental Neuropsychology, 1998
- The Neuropsychiatric InventoryNeurology, 1994
- THE TOPOGRAPHY OF PLAQUES AND TANGLES IN DOWN'S SYNDROME PATIENTS OF DIFFERENT AGESNeuropathology and Applied Neurobiology, 1986
- ALZHEIMER'S PRESENILE DEMENTIA, SENILE DEMENTIA OF ALZHEIMER TYPE AND DOWN'S SYNDROME IN MIDDLE AGE FORM AN AGE RELATED CONTINUUM OF PATHOLOGICAL CHANGESNeuropathology and Applied Neurobiology, 1984